Skip to main content

19-09-2020 | ESMO 2020 | Conference coverage | Video

JAVELIN Bladder 100: Identifying biomarkers for maintenance avelumab

Thomas Powles discusses the key findings from the biomarker analyses of the JAVELIN Bladder 100 study of maintenance avelumab in patients with advanced urothelial cancer (3:56).

This independent video interview was supported by an educational grant from Pfizer and Merck Healthcare KGaA, Darmstadt, Germany

Read transcript